GtoPdb Ligand ID: 10752

Synonyms: PRO 140 | PRO-140 | PRO140
Compound class: Antibody
Comment: Leronlimab (PRO140) is a humanized anti-CCR5 (C-C motif chemokine receptor 5) monoclonal antibody [5-6]. It was originally developed by CytoDyn as a novel strategy to manage CCR5-tropic HIV infection [4].

COVID-19: Leronlimab has been administered to a number of patients with severe COVID-19, to determine its potential to reduce cytokine storm caused by this disease.
Compound class Antibody
International Nonproprietary Names
INN number INN
10751 leronlimab
PRO 140 | PRO-140 | PRO140
Database Links
Specialist databases
IMGT/mAb-DB 807
Other databases
GtoPdb PubChem SID 405560193
Search PubMed clinical trials leronlimab
Search PubMed titles leronlimab
Search PubMed titles/abstracts leronlimab